ClinicalTrials.Veeva

Menu
I

Intermountain Clinical Research | Draper, UT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

fluticasone propionate
azelastine Hcl
azelastineHcl
CC-93538
DX-2930
azelastine HCl
SHP643
BLU-5937
NB-001
S-600918

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 15 total trials

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evalu...

Active, not recruiting
Eosinophilic Esophagitis
Drug: CC-93538
Other: Placebo

This study is an open-label, uncontrolled study design to evaluate the long-term safety and tolerability of treatment with CC-93538. The study will e...

Enrolling
Eosinophilic Esophagitis
Drug: CC-93538

Trial sponsors

Meda Pharmaceuticals logo
Celgene logo
Shire logo
A
Allergy Therapeutics logo
B
Daiichi Sankyo logo
Merck Sharp & Dohme (MSD) logo
N
Shionogi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems